Investigational Drug Information for JNJ-70033093
✉ Email this page to a colleague
What is the development status for investigational drug JNJ-70033093?
JNJ-70033093 is an investigational drug.
There have been 12 clinical trials for JNJ-70033093.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 8th 2023.
The most common disease conditions in clinical trials are Ischemic Attack, Transient, Ischemia, and Cerebral Infarction. The leading clinical trial sponsors are Janssen Research & Development, LLC, Bristol-Myers Squibb, and Janssen Pharmaceutica N.V., Belgium.
Summary for JNJ-70033093
| US Patents | 0 |
| International Patents | 126 |
| US Patent Applications | 17 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2023-03-08) |
| Vendors | 21 |
Recent Clinical Trials for JNJ-70033093
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome | Janssen Research & Development, LLC | Phase 3 |
| A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack | Bristol Myers Squibb Company (BMS) | Phase 3 |
| A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack | Janssen Research & Development, LLC | Phase 3 |
Clinical Trial Summary for JNJ-70033093
Top disease conditions for JNJ-70033093
Top clinical trial sponsors for JNJ-70033093
US Patents for JNJ-70033093
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for JNJ-70033093
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| JNJ-70033093 | Argentina | AR099227 | 2034-01-31 | ⤷ Sign Up |
| JNJ-70033093 | Argentina | AR099550 | 2034-01-31 | ⤷ Sign Up |
| JNJ-70033093 | Argentina | AR101367 | 2034-01-31 | ⤷ Sign Up |
| JNJ-70033093 | Australia | AU2015210904 | 2034-01-31 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
